Life sciences get investment fund:
This article was originally published in Clinica
German companies Corange and Bayerische Vereinsbank and Netherlands-based ING Group are to sponsor a venture capital fund to invest in life science companies. The fund will run for ten years and will be aimed at human and animal health companies among others. Each of the sponsors will invest DM 25 million ($17 million) in the fund and a further DM 50-75 million will be sought from other investors. The fund will have the legal form of a Guernsey limited partnership.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.